Jason Slakter, MD, an ophthalmologist at Vitreous Retina Macula Consultants of New York in New York City, has become the first physician to administer Syfovre, a treatment for geographic atrophy in patients with dry age-related macular degeneration.
Until the recent FDA approval of Syfovre, there was no treatment to address the symptoms of AMD, according to a May 10 press release.
Syfovre slows degeneration of the retinal cells and provides patients with visual function for many more months or years.